Results 221 to 230 of about 106,748 (296)

Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.

JAMA Neurol
Kallin S, Svenningsson A, Olén O, Hedin C, Lycke J, Alping P.   +5 more
europepmc   +1 more source

Rituximab Binding Endows CD20+ Extracellular Vesicles With NK Cell-Activating Properties in B Cell Lymphoma. [PDF]

J Extracell Vesicles
Otero AV, Pérez PS, Gaete-Ramírez B, Cordini G, Norte M, Martínez E, Marsol N, Malusardi C, Rivarola S, Cantillo A, Leicaj ML, Russo C, Braghini JQ, Penas F, Ernst G, Cabral C, Palmer S, Varas-Godoy M, Arruvito L, Ostrowski M.   +19 more
europepmc   +1 more source

Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK‐positive anaplastic large‐cell lymphoma

Histopathology, EarlyView.
Poorly differentiated lung adenocarcinomas with concurrent anaplastic lymphoma kinase (ALK) and CD30 expression closely mimic ALK‐positive anaplastic large‐cell lymphoma, creating a significant diagnostic pitfall. Accurate classification requires comprehensive integration of clinical, radiologic, morphologic, immunophenotypic and molecular findings ...
Jietian Jin, Wenjian Cen, Qin Yan, Yangshan Chen, Chaoyun Huang, Yanfeng Feng, Neng Jiang   +6 more
wiley   +1 more source

Sequential glofitamab and consolidative ASCT plus CAR-T therapy achieved durable remission in relapsed/refractory DLBCL. [PDF]

Blood Sci
Yan S, Wu J, Zhou M, Xiao Y.
europepmc   +1 more source

CD20: A Moving Target?

The Hematologist, 2010
openaire   +1 more source

Cutaneous involvement by myeloid leukaemias: challenging cases with important implications

Histopathology, EarlyView.
Myeloid leukaemias and precursors involving the skin are often challenging to diagnose with varied and overlapping clinical and histopathologic features. Nonetheless, they are critical for pathologists to recognize and accurately classify. This review discusses the clinical, histopathological and genetic features of myelodysplasia cutis (A) and ...
Alexandra C. Hristov
wiley   +1 more source

Comparison of intestinal histopathological changes following teclistamab, BCMA‐directed CAR T, CD19‐directed CAR T and rituximab therapies

Histopathology, EarlyView.
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung, Esther Baranov, Isairis Peralta Valerio, Robin Collingwood, Natalie Respond, Don Siegel, Pooja Devi, Kristen M. Stashek   +7 more
wiley   +1 more source

Analytical validity of CD20 as a biomarker in breast cancer patients using tissue microarrays and whole slide sections. [PDF]

Biomark Med
Özcan D, Nielsen PS, Alsner J, Tramm T.
europepmc   +1 more source

Congenital aleukemic leukemia cutis mimicking infantile hemangioma

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ana Clara Maia Palhano, Fábio Augusto Peroni Garcia, Thais Kohatsu Yanase, Luciana Paula Samorano, Maria Cecilia Rivitti‐Machado, Zilda de Najjar Prado Oliveira   +5 more
wiley   +1 more source

ICSH Guidance on Bone Marrow Examination and Reporting

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber, Alexandar Tzankov, Olga Pozdnyakova, Hiromichi Matsushita, Gina Zini, Leonie Saft, on behalf of the International Council for Standardization in Haematology   +6 more
wiley   +1 more source